High flux detection method for tumor-targeted drugs related genes mutation, primers and reagent thereof
A tumor targeting and gene technology, applied in the field of tumor genes, which can solve the problems of low sensitivity and so on
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0092] In the 21st century, cancer has surpassed coronary heart disease and stroke to become the number one cause of death. Currently, the treatments for malignant tumors include surgery, chemotherapy, radiotherapy, immunotherapy, and targeted drug therapy. Molecular targeted therapy targets key molecules and key sites in the pathogenesis of tumors, has strong selectivity and low toxicity and side effects, and is the development direction and new breakthrough point of tumor treatment. However, the mechanism of tumorigenesis is complex and there are many mutation sites. Screening for gene mutations associated with tumor-targeted drugs is a prerequisite for targeted drug therapy. The U.S. FDA's Tumor Targeted Drug Therapy Manual requires genetic testing for cancer mutations before using targeted gene drugs. Sanger sequencing and fluorescent quantitative PCR are currently the traditional methods used to detect gene mutations associated with tumor-targeted drugs. Sanger sequencin...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com